BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19325497)

  • 1. A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents.
    Wagner KD; Redden L; Kowatch RA; Wilens TE; Segal S; Chang K; Wozniak P; Vigna NV; Abi-Saab W; Saltarelli M
    J Am Acad Child Adolesc Psychiatry; 2009 May; 48(5):519-532. PubMed ID: 19325497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania.
    Hirschfeld RM; Bowden CL; Vigna NV; Wozniak P; Collins M
    J Clin Psychiatry; 2010 Apr; 71(4):426-32. PubMed ID: 20361904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety of divalproex sodium extended-release in children and adolescents with bipolar I disorder.
    Redden L; DelBello M; Wagner KD; Wilens TE; Malhotra S; Wozniak P; Vigna NV; Greco N; Kovacs X; Abi-Saab W; Saltarelli M;
    J Child Adolesc Psychopharmacol; 2009 Feb; 19(1):83-9. PubMed ID: 19232026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, double-blind, placebo-controlled study of divalproex extended release loading monotherapy in ambulatory bipolar spectrum disorder patients with moderate-to-severe hypomania or mild mania.
    McElroy SL; Martens BE; Creech RS; Welge JA; Jefferson L; Guerdjikova AI; Keck PE
    J Clin Psychiatry; 2010 May; 71(5):557-65. PubMed ID: 20361901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
    Sachs GS; Vanderburg DG; Karayal ON; Kolluri S; Bachinsky M; Cavus I
    J Clin Psychiatry; 2012 Nov; 73(11):1412-9. PubMed ID: 23218157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study.
    Tohen M; Vieta E; Goodwin GM; Sun B; Amsterdam JD; Banov M; Shekhar A; Aaronson ST; Bardenstein L; Grecu-Gabos I; Tochilov V; Prelipceanu D; Oliff HS; Kryzhanovskaya L; Bowden C
    J Clin Psychiatry; 2008 Nov; 69(11):1776-89. PubMed ID: 19014751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.
    Bowden CL; Calabrese JR; McElroy SL; Gyulai L; Wassef A; Petty F; Pope HG; Chou JC; Keck PE; Rhodes LJ; Swann AC; Hirschfeld RM; Wozniak PJ
    Arch Gen Psychiatry; 2000 May; 57(5):481-9. PubMed ID: 10807488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open-label trial of divalproex in children and adolescents with bipolar disorder.
    Wagner KD; Weller EB; Carlson GA; Sachs G; Biederman J; Frazier JA; Wozniak P; Tracy K; Weller RA; Bowden C
    J Am Acad Child Adolesc Psychiatry; 2002 Oct; 41(10):1224-30. PubMed ID: 12364844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania.
    Bowden CL; Swann AC; Calabrese JR; Rubenfaer LM; Wozniak PJ; Collins MA; Abi-Saab W; Saltarelli M;
    J Clin Psychiatry; 2006 Oct; 67(10):1501-10. PubMed ID: 17107240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot study.
    Wang Z; Gao K; Kemp DE; Chan PK; Serrano MB; Conroy C; Fang Y; Ganocy SJ; Findling RL; Calabrese JR
    Psychopharmacol Bull; 2010; 43(4):5-21. PubMed ID: 21240149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute efficacy of divalproex sodium versus placebo in mood stabilizer-naive bipolar I or II depression: a double-blind, randomized, placebo-controlled trial.
    Muzina DJ; Gao K; Kemp DE; Khalife S; Ganocy SJ; Chan PK; Serrano MB; Conroy CM; Calabrese JR
    J Clin Psychiatry; 2011 Jun; 72(6):813-9. PubMed ID: 20816041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS; Konarski JZ; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes.
    Ketter TA; Kalali AH; Weisler RH;
    J Clin Psychiatry; 2004 May; 65(5):668-73. PubMed ID: 15163253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divalproex in the treatment of acute bipolar depression: a preliminary double-blind, randomized, placebo-controlled pilot study.
    Ghaemi SN; Gilmer WS; Goldberg JF; Zablotsky B; Kemp DE; Kelley ME; Bauer AD; Fleck J; Filkowski MM; Stan VA; Dunn RT
    J Clin Psychiatry; 2007 Dec; 68(12):1840-4. PubMed ID: 18162014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder.
    Pavuluri MN; Henry DB; Findling RL; Parnes S; Carbray JA; Mohammed T; Janicak PG; Sweeney JA
    Bipolar Disord; 2010 Sep; 12(6):593-605. PubMed ID: 20868458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.
    Scheffer RE; Kowatch RA; Carmody T; Rush AJ
    Am J Psychiatry; 2005 Jan; 162(1):58-64. PubMed ID: 15625202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
    Yatham LN; Vieta E; Young AH; Möller HJ; Paulsson B; Vågerö M
    Int Clin Psychopharmacol; 2007 Jul; 22(4):212-20. PubMed ID: 17519644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divalproex sodium for pediatric mixed mania: a 6-month prospective trial.
    Pavuluri MN; Henry DB; Carbray JA; Naylor MW; Janicak PG
    Bipolar Disord; 2005 Jun; 7(3):266-73. PubMed ID: 15898964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127).
    Suppes T; Vieta E; Liu S; Brecher M; Paulsson B;
    Am J Psychiatry; 2009 Apr; 166(4):476-88. PubMed ID: 19289454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.